CRESCENT PHARMA LIMITEDActive
Key figures
Ratios
2021Balance sheet structure
Filed accounts2020–2021
| 2020 | 2021 | |
|---|---|---|
| Turnover | 105,278,067 | 96,475,385 |
| Profit for the year | 10,853,193 | 1,253,649 |
| Cash at bank and in hand | 7,202,318 | 2,991,505 |
| Total assets | 78,789,944 | 72,747,290 |
| Total liabilities | 49,495,445 | 49,502,308 |
| Net assets / total equity | 29,229,975 | 23,191,755 |
| Average number of employees | 68 | 55 |
| Average pay (per year) | 217,332 | 43,263 |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
Principal activity
Accounts 2021The principal activity of the company continued to be that of wholesale distribution and manufacturing of pharmaceutical products.
As described in the company's latest filed accounts.
Summary: CRESCENT PHARMA LIMITED
Company
CRESCENT PHARMA LIMITED is a private limited company registered with Companies House under company number 04750933. It was incorporated on 1 May 2003. Its status is active. The registered office is in Basingstoke (RG21). Its nature of business (SIC 2007) is manufacture of basic pharmaceutical products (21100), manufacture of pharmaceutical preparations (21200), wholesale of pharmaceutical goods (46460).
Accounts
The latest accounts in the database are for 2021 (period ending 31 Dec 2021); the company files full accounts. Turnover was £96,475,385. Profit for the year was £1,253,649. Net assets were £23,191,755, down 20.7% on the previous year. Cash at bank and in hand was £2,991,505. Total assets were £72,747,290 and total liabilities £49,502,308. The company had an average of 55 employees. Figures are available for 2 financial years (2020–2021).
Control and charges
2 persons with significant control are registered. 5 of 7 registered charges are outstanding.
Filing deadlines
The next accounts are due by 30 Sep 2026. The next confirmation statement is due by 15 Jan 2027.